FIELD: medicine, immunology.
SUBSTANCE: one should carry out reaction of blast-transformation, detect proliferation of T-lymphocytes activated with antibodies to CD3 in the presence of interleukin-7 (ACT IL-7) and in the presence of interleukin-7 and dexametazone (ACT IL-7 D), calculate the index for dexametazone action as the ratio of ACT IL-7 to ACT IL-7 D, moreover, the value of dexametazone action index being above 1.2 indicates increased production of cytokins that suppress T-lymphocytes in neonatals. The method enables to detect functional defect of immune system that characterizes neonatal period.
EFFECT: higher efficiency of detection.
2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| WAY OF ESTIMATION OF SYNERGISTIC ACTION OF GLUCOCORTICOIDS AND INTERLEUKIN-7 ON FUNCTIONAL MATURING OF T-LYMPHOCYTES OF NEWBORNS | 2007 |
|
RU2363954C2 |
| APPLICATION OF INHIBITING TGF-beta1 PEPTIDES FOR PREPARATION OF AGENT MODULATING IMMUNE RESPONSE | 2005 |
|
RU2420307C2 |
| MEDICINAL PREPARATION TO PREVENT TRANSPLANT DETACHMENT, MONOCLONAL ANTIBODY TO CD3 ANTIGEN OF HUMAN T-LYMPHOCYTES, HYBRIDOME AND METHOD TO TREAT PATIENTS SUFFERING ACUTE TRANSPLANT DETACHMENT REACTION FOLLOWING KIDNEY TRANSPLANTATION | 2000 |
|
RU2179862C1 |
| PHARMACEUTICAL COMPOSITION FOR IMMUNE DISEASE TREATMENT | 2000 |
|
RU2203682C2 |
| IMMUNOBIOLOGICAL AGENT TO ENHANCE CELLULAR RESPONSE AGAINST HEPATITIS C VIRUS | 2023 |
|
RU2811136C1 |
| METHOD AND DEVICE FOR MODULATING IMMUNE RESPONSE | 1999 |
|
RU2225197C2 |
| NEW SUBPOPULATION OF TREG CD8CD45RC CELLS AND ITS APPLICATIONS | 2016 |
|
RU2766691C2 |
| MONOCLONAL ANTIBODY SUPPRESSING THE IMMUNOSUPPRESSIVE FUNCTIONS OF PATHOGENS, ANTIGEN-BINDING FRAGMENT OF THE SPECIFIED ANTIBODY AND HYBRIDOMAS PRODUCING THE SPECIFIED ANTIBODY | 2017 |
|
RU2751918C2 |
| METHOD FOR PRECLINICAL TESTING OF IMMUNOMODULATORY AGENTS | 2010 |
|
RU2519641C2 |
| SOLUBLE MEDIATOR | 2012 |
|
RU2660580C2 |
